Get started
Sandu Pharmaceuticals LimitedSandu Pharmaceuticals LimitedSandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasMindsTechnicalsSeasonals

Chart


Full chart

Key stats


Market capitalization
‪381.61 M‬ INR
Dividend yield (indicated)
2.03%
Price to earnings Ratio (TTM)
23.83
Basic EPS (TTM)
1.69 INR
Net income (FY)
‪15.52 M‬ INR
Revenue (FY)
‪671.92 M‬ INR
Shares float
‪4.71 M‬
Beta (1Y)
0.68

Employees


Employees (FY)
303
Change (1Y)
+20 +7.07%
Revenue / Employee (1Y)
‪2.22 M‬ INR
Net income / Employee (1Y)
‪51.21 K‬ INR

About Sandu Pharmaceuticals Limited


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Umesh Bhaskar Sandu
Website
sandu.in
Headquarters
Mumbai
Founded
1899
ISIN
INE751D01014
FIGI
BBG000DX3VG3
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. It offers its products under the Berbenteron suspension, Berbenteron tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin and Pentazyme brands. The company was founded on May 10, 1899 and is headquartered in Mumbai, India.

Check out other big names from the same industry as SANDUPHQ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SANDUPHQ is 39.49 INR — it has decreased by −1.74% in the past 24 hours. Watch Sandu Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Sandu Pharmaceuticals Limited stocks are traded under the ticker SANDUPHQ.
SANDUPHQ stock has risen by 2.33% compared to the previous week, the month change is a −8.29% fall, over the last year Sandu Pharmaceuticals Limited has showed a −32.50% decrease.
SANDUPHQ reached its all-time high on Apr 26, 2022 with the price of 86.00 INR, and its all-time low was 4.00 INR and was reached on Nov 3, 2003. View more price dynamics on SANDUPHQ chart.
See other stocks reaching their highest and lowest prices.
SANDUPHQ stock is 5.21% volatile and has beta coefficient of 0.68. Track Sandu Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Sandu Pharmaceuticals Limited there?
Today Sandu Pharmaceuticals Limited has the market capitalization of ‪381.61 M‬, it has decreased by −3.55% over the last week.
Yes, you can track Sandu Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
SANDUPHQ net income for the last quarter is ‪5.24 M‬ INR, while the quarter before that showed ‪2.23 M‬ INR of net income which accounts for 134.80% change. Track more Sandu Pharmaceuticals Limited financial stats to get the full picture.
Yes, SANDUPHQ dividends are paid annually. The last dividend per share was 0.80 INR. As of today, Dividend Yield (TTM)% is 2.03%. Tracking Sandu Pharmaceuticals Limited dividends might help you take more informed decisions.
Sandu Pharmaceuticals Limited dividend yield was 1.63% in 2024, and payout ratio reached 49.81%. The year before the numbers were 1.39% and 52.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 8, 2025, the company has 303 employees. See our rating of the largest employees — is Sandu Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sandu Pharmaceuticals Limited EBITDA is ‪28.26 M‬ INR, and current EBITDA margin is 4.11%. See more stats in Sandu Pharmaceuticals Limited financial statements.
Like other stocks, SANDUPHQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sandu Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sandu Pharmaceuticals Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sandu Pharmaceuticals Limited stock shows the sell signal. See more of Sandu Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.